Competitor Analysis: Cardiovascular Peptides -





The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, arrhythmias, hypertension, peripheral and cerebral vascular diseases, and hematologic disorders provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.  

The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:  

•Drug Codes,
•Target / Mechanism of Action,
•Class of Compound,
•Company,
•Product category,
•Indication,
•R&D Stage and
•additional comments with a hyperlink leading to the source of information.
Index
•Heart Failure
•Myocardial Infarction
•Peripheral & Cerebral Vascular Diseases
•Arrhythmias
•Hypertension
•Prevention of Thrombosis
•Intensive Care & Reperfusion Injuries
•Hematology
•About La Merie
 

About Competitor Analysis Series
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
 


 
 

  

 •Heart Failure
•Myocardial Infarction
•Peripheral & Cerebral Vascular Diseases
•Arrhythmias
•Hypertension
•Prevention of Thrombosis
•Intensive Care & Reperfusion Injuries
•Hematology
•About La Merie